StocksFundsScreenerSectorsWatchlists
NGVT

NGVT - Ingevity Corp Stock Price, Fair Value and News

48.65USD+0.21 (+0.43%)Delayed as of 28 Mar 2024, 10:58 am ET

Market Summary

NGVT
USD48.65+0.21
Delayedas of 28 Mar 2024, 10:58 am
0.43%

NGVT Alerts

  • Big fall in earnings (Y/Y)
  • Losses in recent quarter

NGVT Stock Price

View Fullscreen

NGVT RSI Chart

NGVT Valuation

Market Cap

1.8B

Price/Earnings (Trailing)

-325.05

Price/Sales (Trailing)

1.04

EV/EBITDA

14.77

Price/Free Cashflow

8.56

NGVT Price/Sales (Trailing)

NGVT Profitability

EBT Margin

-0.60%

Return on Equity

-0.86%

Return on Assets

-0.21%

Free Cashflow Yield

11.68%

NGVT Fundamentals

NGVT Revenue

Revenue (TTM)

1.7B

Rev. Growth (Yr)

-3.1%

Rev. Growth (Qtr)

-16.66%

NGVT Earnings

Earnings (TTM)

-5.4M

Earnings Growth (Yr)

-848.72%

Earnings Growth (Qtr)

-563.49%

Breaking Down NGVT Revenue

52 Week Range

41.4874.74
(Low)(High)

Last 7 days

4.7%

Last 30 days

-0.5%

Last 90 days

-0.9%

Trailing 12 Months

-36.6%

How does NGVT drawdown profile look like?

NGVT Financial Health

Current Ratio

1.81

Debt/Equity

2.19

Debt/Cashflow

0.15

NGVT Investor Care

Buy Backs (1Y)

2.85%

Diluted EPS (TTM)

-0.16

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20231.7B1.7B1.7B1.7B
20221.5B1.5B1.6B1.7B
20211.2B1.3B1.4B1.4B
20201.3B1.2B1.2B1.2B
20191.2B1.2B1.3B1.3B
2018989.1M1.0B1.1B1.1B
2017927.2M942.1M953.8M972.4M
2016923.4M908.9M906.5M908.3M
20151.0B996.9M977.6M958.3M
20140001.0B

Tracking the Latest Insider Buys and Sells of Ingevity Corp

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Feb 28, 2024
white richard allen jr
acquired
-
-
8,236
svp and pres, perf chemicals
Feb 28, 2024
woodcock stuart edward jr.
sold (taxes)
-37,030
45.27
-818
evp and pres, perf materials
Feb 28, 2024
stunyo christine
sold (taxes)
-15,889
45.27
-351
svp, chief hr officer
Feb 28, 2024
hall mary dean
acquired
-
-
12,710
evp & cfo
Feb 28, 2024
woodcock stuart edward jr.
acquired
-
-
9,201
evp and pres, perf materials
Feb 28, 2024
platt phillip john
acquired
-
-
3,591
cao & vp, bus transform lead
Feb 28, 2024
hulme steven paul
sold (taxes)
-11,181
45.27
-247
svp and pres, apt
Feb 28, 2024
fortson john c.
sold (taxes)
-207,880
45.27
-4,592
president & ceo
Feb 28, 2024
cozad stacy
sold (taxes)
-28,384
45.27
-627
evp, gen. counsel & secretary
Feb 28, 2024
white richard allen jr
sold (taxes)
-24,128
45.27
-533
svp and pres, perf chemicals

1–10 of 50

Which funds bought or sold NGVT recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Mar 22, 2024
PNC FINANCIAL SERVICES GROUP, INC.
reduced
-12.22
-90,084
606,070
-%
Mar 22, 2024
Livelsberger Financial Advisory
new
-
2,030
2,030
-%
Mar 21, 2024
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND
unchanged
-
-781
94,487
-%
Mar 11, 2024
VANGUARD GROUP INC
added
4.28
5,849,670
176,760,000
-%
Mar 01, 2024
GOLDMAN SACHS GROUP INC
added
79.92
4,714,370
10,723,900
-%
Mar 01, 2024
Pineridge Advisors LLC
new
-
1,889
1,889
-%
Feb 28, 2024
AMERICAN INTERNATIONAL GROUP, INC.
reduced
-0.8
-15,326
933,256
-%
Feb 26, 2024
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
unchanged
-
-4,000
523,000
-%
Feb 20, 2024
Quarry LP
reduced
-68.5
-19,641
8,925
-%
Feb 16, 2024
HARBOUR INVESTMENTS, INC.
unchanged
-
-6.00
803
-%

1–10 of 46

Are Funds Buying or Selling NGVT?

Are funds buying NGVT calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own NGVT
No. of Funds

Unveiling Ingevity Corp's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 28, 2024
inclusive capital partners, l.p.
3.2%
1,151,405
SC 13D/A
Feb 13, 2024
vanguard group inc
10.33%
3,743,322
SC 13G/A
Feb 08, 2024
wellington management group llp
5.93%
2,148,379
SC 13G
Feb 07, 2024
victory capital management inc
-
1,854,554
SC 13G
Jan 22, 2024
blackrock inc.
16.6%
6,003,674
SC 13G/A
May 30, 2023
inclusive capital partners, l.p.
6.6%
2,401,405
SC 13D/A
Feb 10, 2023
vanguard group inc
10.06%
3,761,430
SC 13G/A
Feb 09, 2023
vanguard group inc
9.90%
3,700,520
SC 13G/A
Jan 26, 2023
blackrock inc.
12.2%
4,567,023
SC 13G/A
Jan 20, 2023
blackrock inc.
12.2%
4,567,023
SC 13G

Recent SEC filings of Ingevity Corp

View All Filings
Date Filed Form Type Document
Mar 22, 2024
DEFR14A
DEFR14A
Mar 14, 2024
8-K
Current Report
Mar 11, 2024
ARS
ARS
Mar 11, 2024
DEF 14A
DEF 14A
Mar 11, 2024
DEFA14A
DEFA14A
Mar 01, 2024
4
Insider Trading
Mar 01, 2024
PRE 14A
PRE 14A
Mar 01, 2024
4
Insider Trading
Mar 01, 2024
4
Insider Trading
Mar 01, 2024
4
Insider Trading

What is the Fair Value of NGVT?

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Cheap
or
Expensive?


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks

Peers (Alternatives to Ingevity Corp)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
54.1B
12.4B
4.35% -13.03%
23.14
4.35
-3.54% 3.06%
41.0B
44.6B
3.97% 15.31%
62.17
0.92
-21.58% -85.78%
18.5B
10.9B
9.50% 60.59%
9.43
1.69
13.10% 3.48%
17.3B
7.0B
9.72% 17.97%
54.01
2.49
-7.26% -53.23%
15.1B
9.6B
-1.41% -42.03%
9.61
1.57
31.38% -41.50%
11.7B
9.2B
11.83% 15.45%
13.07
1.27
-12.95% 12.74%
MID-CAP
5.1B
3.9B
10.48% 18.45%
11.45
1.3
-9.12% 26.64%
5.0B
922.4M
4.26% 25.29%
45.92
5.4
-2.11% 3.01%
3.9B
3.1B
6.32% 3.93%
51.51
1.25
-7.48% -89.19%
3.0B
3.1B
1.68% 6.21%
6.45
0.95
-15.54% -65.21%
SMALL-CAP
1.2B
404.0M
0.11% 32.60%
36.59
3
24.06% -25.72%
735.6M
1.5B
-7.73% -28.05%
13.47
0.48
-21.18% -60.55%
167.5M
357.7M
4.87% 12.84%
8.24
0.47
-5.20% 66.55%
113.5M
21.4M
2.78% 13.89%
13.5
5.31
-45.68% 139.98%
3.7M
-
-80.00% -99.58%
-0.01
0.01
- -

Ingevity Corp News

Latest updates
Simply Wall St • 22 Mar 2024 • 12:08 pm
Seeking Alpha • 22 Feb 2024 • 08:00 am
Zacks Investment Research • 22 Feb 2024 • 08:00 am
Zacks Investment Research • 4 months ago

Ingevity Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue-16.7%372446482393384482420383336377358320326332271288303360353277279
Gross Profit-53.9%60.0012915313010517615113810514214012612714084.0011511114013497.0098.00
  S&GA Expenses8.5%43.0040.0052.0049.0056.0054.0049.0040.0048.0044.0048.0040.0042.0035.0035.0039.0041.0041.0043.0039.0036.00
  R&D Expenses-7.7%7.008.008.009.007.008.008.007.007.007.006.007.006.005.005.006.005.005.005.005.005.00
EBITDA Margin-44.7%0.12*0.22*0.24*0.26*0.26*0.27*0.23*0.23*0.23*0.24*0.33*0.30*---------
Interest Expenses97.8%35.0018.0025.0015.0026.007.0018.0011.0016.0011.0013.0012.001.0014.007.0017.0015.0019.007.0014.0011.00
Income Taxes-639.1%-37.207.0012.0013.004.0020.0017.0017.007.00-4.8029.0013.0020.0018.005.0010.0011.0018.0016.00-2.00
Earnings Before Taxes-579.8%-15432.0048.0064.0020.0096.0077.0078.0036.00-9.0074.0062.0066.0088.0025.0055.0055.0077.0073.0023.0044.00
EBT Margin-106.2%-0.01*0.10*0.13*0.15*0.16*0.18*0.12*0.12*0.12*0.14*0.22*0.19*---------
Net Income-563.5%-11625.0036.0051.0016.0075.0060.0061.0029.00-4.2044.0049.0046.0070.0020.0045.0044.0060.0057.0023.0042.00
Net Income Margin-104.3%0.00*0.07*0.10*0.12*0.13*0.14*0.10*0.09*0.08*0.10*0.16*0.15*---------
Free Cashflow-58.3%45.0010748.005.0098.0010091.0024.0076.0010066.0051.00---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets-5.2%2,6232,7672,8282,7722,7372,3352,3662,4562,4692,4262,3892,3432,3352,2582,1962,3532,1422,1192,1302,1071,315
  Current Assets-10.3%659735764716683645678733725720670642629601580725463499492455423
    Cash Equivalents13.5%96.0085.0068.0078.0077.0072.0013122327526923323826119817830365.0076.0053.0040.0078.00
  Inventory-20.1%309387387361335282277260241228215204189204224236213210221229191
  Net PPE----------701700698704685658660665642638629524
  Goodwill1.4%528520527522519110411433442441449448445428416417436416426432131
Liabilities-2.7%1,9922,0482,1142,0472,0381,7021,7121,7701,7951,7821,7011,6811,6921,6411,6731,8511,6111,6761,7291,749977
  Current Liabilities18.9%363305311279304290267552269248233225223179188208216209216198183
  Long Term Debt-5.9%1,3831,4701,5261,5031,4731,1531,1769461,2501,2541,2591,2631,2671,2771,3091,4681,2281,2941,3631,403741
    LT Debt, Current2713.3%84.003.001.001.001.001.001.0032020.0020.0020.0020.0026.0022.0022.0022.0023.0023.0022.0018.0011.00
Shareholder's Equity-12.1%631719714726698634654686674645689661642617523502531443401359339
  Retained Earnings-10.4%1,0021,1191,0941,0581,008992917857796767771727678632562542497453393336314
  Additional Paid-In Capital1.4%16516316415915314814314013613313012512111711611411311110810498.00
Shares Outstanding0.0%36.0036.0036.0037.0037.0037.0038.0039.0039.0039.0040.0040.00---------
Minority Interest----------------------
Float---2,102---2,401---3,237---2,162---4,384--
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations-58.3%44,600106,90048,4005,20098,500100,10090,50024,30076,300100,10065,80051,100153,30090,00048,90060,20085,500118,70079,500-8,00085,600
  Share Based Compensation483.3%2,300-6004,9004,0005,0004,4003,7003,0002,5003,1004,2002,5004,1001,1002,4008001,3003,6003,3004,1002,400
Cashflow From Investing39.7%-21,000-34,800-23,4001,900-407,200-86,100-28,400-30,200-55,200-26,200-39,900-17,300-32,200-41,000-17,200-20,200-35,900-23,100-30,000-569,300-38,100
Cashflow From Financing87.8%-6,500-53,300-34,500-5,600313,000-71,600-147,000-46,300-12,800-36,700-31,500-52,100-65,000-31,100-157,300203,200-64,400-71,200-34,600539,400-26,200
  Buy Backs---58,70033,4006,00049,30049,50040,4009,10032,20028,70039,40055,600--32,400-3,100-3,30029,300

NGVT Income Statement

2023-12-31
Consolidated Statements of Operations - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]   
Net sales$ 1,692.1$ 1,668.3$ 1,391.5
Cost of sales1,220.21,098.2878.7
Gross profit471.9570.1512.8
Selling, general, and administrative expenses183.7198.8179.3
Research and technical expenses31.830.326.3
Restructuring and other (income) charges, net170.213.816.2
Acquisition-related costs3.65.00.6
Other (income) expense, net5.7(1.7)79.9
Interest expense93.361.851.7
Interest income(6.3)(7.5)(4.0)
Income (loss) before income taxes(10.1)269.6162.8
Provision (benefit) for income taxes(4.7)58.044.7
Net income (loss)$ (5.4)$ 211.6$ 118.1
Per share data   
Basic earnings (loss) per share (usd per share)$ (0.15)$ 5.54$ 2.97
Diluted earnings (loss) per share (usd per share)$ (0.15)$ 5.50$ 2.95

NGVT Balance Sheet

2023-12-31
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Assets  
Cash and cash equivalents$ 95.9$ 76.7
Accounts receivable, net of allowance of $1.1 million - 2023 and $0.5 million - 2022182.0224.8
Inventories, net308.8335.0
Prepaid and other current assets71.946.8
Current assets658.6683.3
Property, plant, and equipment, net762.2798.6
Operating lease assets, net67.156.6
Goodwill527.5518.5
Other intangibles, net336.1404.8
Deferred income taxes11.65.7
Restricted investment, net of allowance of $0.2 million - 2023 and $0.6 million - 202279.178.0
Strategic investments99.2109.8
Other assets81.981.2
Total Assets2,623.32,736.5
Liabilities  
Accounts payable158.4174.8
Accrued expenses72.354.4
Accrued payroll and employee benefits19.953.3
Current operating lease liabilities18.716.5
Notes payable and current maturities of long-term debt84.40.9
Income taxes payable9.23.6
Current liabilities362.9303.5
Long-term debt including finance lease obligations1,382.81,472.5
Noncurrent operating lease liabilities48.640.8
Deferred income taxes70.9106.5
Other liabilities126.7114.9
Total Liabilities1,991.92,038.2
Equity  
Preferred stock (par value $0.01 per share; 50,000,000 shares authorized; zero issued and outstanding at 2023 and 2022)0.00.0
Common stock (par value $0.01 per share; 300,000,000 shares authorized; 43,446,513 and 43,228,172 issued and 36,233,092 and 37,298,989 outstanding at 2023 and 2022, respectively)0.40.4
Additional paid-in capital164.9153.0
Retained earnings1,002.31,007.7
Accumulated other comprehensive income (loss)(26.7)(46.8)
Treasury stock, common stock, at cost (7,213,421 and 5,929,183 shares at 2023 and 2022, respectively)(509.5)(416.0)
Total Ingevity stockholders' equity631.4698.3
Total Liabilities and Equity$ 2,623.3$ 2,736.5
NGVT
Ingevity Corporation manufactures and sells specialty chemicals and activated carbon materials in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products primarily for use in gasoline vapor emission control systems in cars, motorcycles, trucks, and boats. This segment also produces other activated carbon products for use in various applications, including food, water, beverage, and chemical purification. The Performance Chemicals segment comprises of pavement technologies, industrial specialties, and engineered polymers. It manufactures products derived from crude tall oil and lignin extracted from the kraft pulping process, as well as caprolactone monomers and derivatives derived from cyclohexanone and hydrogen peroxide. This segment's products are used in various applications comprising warm mix paving, pavement preservation, pavement reconstruction and recycling, road striping, oil well service additives, oil production, and downstream applications; and adhesives, agrochemical dispersants, lubricants, printing inks, industrial intermediates and oilfield, coatings, resins, elastomers, bioplastics, and medical devices. The company was founded in 1964 and is headquartered in North Charleston, South Carolina.
 CEO
 WEBSITEwww.ingevity.com
 EMPLOYEES2050

Ingevity Corp Frequently Asked Questions


What is the ticker symbol for Ingevity Corp? What does NGVT stand for in stocks?

NGVT is the stock ticker symbol of Ingevity Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Ingevity Corp (NGVT)?

As of Wed Mar 27 2024, market cap of Ingevity Corp is 1.76 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of NGVT stock?

You can check NGVT's fair value in chart for subscribers.

What is the fair value of NGVT stock?

You can check NGVT's fair value in chart for subscribers. The fair value of Ingevity Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Ingevity Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for NGVT so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Ingevity Corp a good stock to buy?

The fair value guage provides a quick view whether NGVT is over valued or under valued. Whether Ingevity Corp is cheap or expensive depends on the assumptions which impact Ingevity Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NGVT.

What is Ingevity Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Mar 27 2024, NGVT's PE ratio (Price to Earnings) is -325.05 and Price to Sales (PS) ratio is 1.04. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NGVT PE ratio will change depending on the future growth rate expectations of investors.